|
|
||||||||
in vivo



* Department of Surgery, Malmö University Hospital, Lund University, Malmö;
Active Biotech Research, Lund, Sweden; and
Sidney Kimmel Cancer Center, La Jolla, California
Correspondence: Henrik Thorlacius, Department of Surgery, Malmö University Hospital, Lund University, 20502 Malmö, Sweden.
The immunomodulator Linomide (roquinimex) ameliorates the
development of numerous inflammatory and immunological diseases,
including sepsis, arthritis, and encephalomyelitis. However, the
mechanism underlying this protective effect of Linomide remains
unclear. In this study, we wanted to evaluate the effect of Linomide
treatment on the different steps in the extravasation process of
leukocytes stimulated by tumor necrosis factor
(TNF-
) in
vivo. For this purpose, we used intravital microscopy in the
mouse cremaster muscle microcirculation. We found that pretreatment
with Linomide dose-dependently (3300 mg/kg) reduced TNF-
-induced
leukocyte adhesion and tissue recruitment. Notably, at 300 mg/kg of
Linomide, the leukocyte response to TNF-
was nearly abolished, i.e.
leukocyte adhesion was decreased by 83% and recruitment by 86%. In
fact, the anti-inflammatory effect of this dose of Linomide
corresponded in magnitude to the potency of 10 mg/kg of dexamethasone.
Moreover, administration of Linomide did not alter the systemic
leukocyte counts. On the other hand, 110 mg/kg of dexamethasone
decreased the circulating number of mononuclear leukocytes by 77%.
Taken together, our novel findings demonstrate that Linomide is a
potent inhibitor of leukocyte adhesion and recruitment in
cytokine-activated tissues. These data may help explain the documented
protection provided by Linomide in inflammatory diseases characterized
by cytokine activation and leukocyte accumulation.
Key Words: dexamethasone microcirculation P-selectin rolling
This article has been cited by other articles:
![]() |
R. Schramm and H. Thorlacius Staphylococcal Enterotoxin B-Induced Acute Inflammation Is Inhibited by Dexamethasone: Important Role of CXC Chemokines KC and Macrophage Inflammatory Protein 2 Infect. Immun., May 1, 2003; 71(5): 2542 - 2547. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |